Additionally, our team has just reviewed FGF19’s function and therapeutic potential in skeletal development and diseases, describing its potential physiological role in cartilage and endochondral ossification, and its role in bone diseases including Apert syndrome, osteoarthritis, and osteoporosis [10]. This evidence concerns the gene FGF19 and osteoporosis.